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Abstract Insulin resistance and altered endocrine pan-
creasfunctionarecentralpathophysiologicalfeaturesoftype
2diabetesmellitus(T2DM).TheGoto-Kakizaki(GK)ratisa
model of spontaneous T2DM characterised by reduced beta
cell mass and genetically determined glucose intolerance
and altered insulin secretion. To identify genetic determi-
nants of endocrine pancreas histopathology, we carried out
quantitative trait locus (QTL) mapping of histological phe-
notypes (beta cell mass -BCM and insulin-positive cell area
-IPCA) and plasma concentration of hormones and growth
factors in a F2 cohort derived from GK and normoglycemic
Brown Norway rats. Although IPCA and BCM in the duo-
denal region of the pancreas were highly positively corre-
lated (P\10
-6), and similarly in the splenic region, both
measures were poorly correlated when comparing duodenal
and splenic phenotypes. Strongest evidence of linkage to
pancreas morphological traits was obtained between BCM
and chromosome 10 (LOD 3.2). Evidence of signiﬁcant
linkage(LOD4.2)toplasmacorticosteronewasdetectedina
region of chromosome 1 distal to other QTLs previously
identiﬁed in the GK. Male-speciﬁc genetic effects were
detected,includinglinkages(LOD[4)togrowthhormome
(GH) on chromosome 6 and prolactin on chromosome 17.
These data suggest independent genetic control of the
structure and function of ontologically different regions of
the endocrine pancreas. Novel QTLs for corticosterone,
prolactin and GH may contribute to diabetes in the GK. The
QTLs that we have identiﬁed in this, and previous genetic
studies collectively underline the complex and multiple
mechanisms involved in diabetes in the GK strain.
Introduction
Pancreatic islet anomalies and reduced sensitivity of
peripheral tissues to insulin action (insulin resistance) are
central features in the pathogenesis of type 2 diabetes
(T2D) (Kahn 2003). Owing to the widely accepted exis-
tence of decreased beta cell mass and function in T2D
(Kahn et al. 2009), there is growing interest in under-
standing structural and functional changes in pancreatic
islets in diabetes and their relationships with insulin
resistance. The endocrine part of the pancreas, which
produces insulin, glucagon somatostatin and the pancreatic
polypeptide, represents only 10% of the pancreas. It
undergoes complex in utero and postnatal developmental
maturation and functional processes involving intrinsic and
circulating signalling factors (Habener et al. 2005; Puri and
Hebrok 2010). Another level of complexity lies in the
organogenesis of the pancreas which differentiates from
two separate buds (ventral and dorsal) of cells of the gut
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fusion of two primordial organs (Edlund 2001). This
developmental regionalisation of the endocrine pancreas
has long term structural and functional consequences on
islet density and beta cell mass content in the corre-
sponding regions of adult pancreas (Rahier et al. 2008;
Spooner et al. 1970).
For obvious ethical reasons the regulation of structural
and functional pancreatic phenotypes are difﬁcult or
impossible to investigate directly in diabetic patients and
healthy individuals. Animal models of diabetes mellitus
are crucially important experimental systems to investi-
gate islet structural and functional variables and their
genetic control. The inbred Goto-Kakizaki (GK) rat strain
is a model of spontaneous diabetes, which develops as a
consequence of the expression of naturally occurring
disease gene variants isolated from an outbred Wistar
colony. Even though the GK strain was derived following
repeated breeding of rats selected solely on the basis of
glucose intolerance (Goto et al. 1988) it exhibits a wide
range of additional anomalies, including altered insulin
secretion in vivo and in vitro, insulin resistance and
reduced beta-cell mass (Portha 2005). Genetic studies in
this model have primarily focused on the identiﬁcation of
genetic loci (quantitative trait loci—QTLs) involved in
the regulation of diabetes and obesity intermediate
physiological phenotypes (glucose tolerance, insulin
secretion, body weight, adiposity, lipoprotein metabolism)
(Argoud et al. 2006; Gauguier et al. 1996), and
1HN M R
metabonomic-derived metabolic variables (Dumas et al.
2007).
In the present work, we investigated the genetic control
of phenotypes directly or indirectly relevant to beta cell
structure and function in adult rats of an experimental cross
derived from the GK and normoglycemic Brown Norway
(BN) strains. We identiﬁed QTLs linked to beta cell mass
and plasma concentration of corticosterone, prolactin and
growth hormone. Results from this, and previous genetic
studies, provide a comprehensive mapping of naturally
occurring genetic variants that cause diabetes in the GK
and further emphasise the complex etiology of diabetes in
this model.
Methods
Animals
BN/Crl rats were obtained from a commercial supplier
(Charles River Laboratories, Margate, UK). Rats of the
GK/Ox colony were bred locally. All rats were maintained
on a 12-h light and dark cycle and had free access to water
and standard laboratory chow pellets (ERB, Whitam, UK).
All procedures were carried out in accordance with
national and institutional guidelines.
Two reciprocal F1 generations (female GK 9 male BN
and female BN 9 male GK) were produced. A cohort of
170 F2 rats (84 males and 86 females) was independently
derived from F1 animals, 88 originated from a GK female
and 82 from a GK male. Progenies were weaned at
21 days. At 2 months of age, rats were fasted overnight for
16–18 h and blood samples were collected at about 9am
into EDTA-tubes. Plasma was separated by centrifugation
at 3,000 RPM and immediately stored at -80C until
assays. Rats were then killed by decapitation. The spleen of
F2 hybrids was dissected and stored at -80C for DNA
preparation. The pancreas of each hybrid was dissected and
weighed prior to immunocytochemistry and morphometry
studies.
Pancreatic islet immunocytochemistry
and morphometry
Islet morphology was evaluated by immunostaining of
pancreatic sections for insulin. The duodenal and splenic
pancreatic regions were dissected, independently weighed,
ﬁxed in aqueous Bouin’s solution and embedded in
Paraplast (Labonord, France). Parafﬁn pancreatic blocks
were serially sectioned (7 lm) throughout the organ length
to avoid possible bias caused by regional changes in islet
distribution or cell composition, and mounted on slides.
Seven sections were chosen at a ﬁxed interval through the
pancreatic block (every 35th section) to provide a repre-
sentation of the structure of the islets across whole pan-
creas. Parafﬁn sections were deparafﬁnized, rehydrated and
immunostained for insulin using a peroxidase indirect-
labelling technique.
Sections were incubated for 1 h with a guinea pig anti-
insulin serum (ﬁnal dilution 1:1,000; ICN, Aurora, OH)
and incubated for 45 min with peroxidase-conjugated
rabbit anti–guinea pig IgG (ﬁnal dilution 1:20; Dako,
Carpinteria, CA). The activity of the antibody-peroxidase
complex was revealed with DAB (Diaminobenzidine-tet-
rahydrochloride) using a peroxidase substrate kit DAB
(Biosys-Vector, Compie `gne, France). A standard concen-
tration of hematoxylin was used as a counterstain. After
staining, sections were mounted in Eukitt (Kindler,
Freiburg, Germany).
Quantitative measurements of islet structural pheno-
types were performed using an Olympus BH2 microscope
connected via a colour video camera to a computer, using
Imagenia 2000 software (Biocom, Les Ulis, France). Area
of insulin-positive cells and that of total pancreatic sections
were measured in each section. Beta cell area was then
determined by calculating the ratio between the areas
according to stereological methods (Kargar and Ktorza
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1232008). Finally, total beta-cell mass for the ventral and
dorsal parts of the pancreas of each F2 hybrid was derived
by multiplying this ratio by the weight of the pancreatic
region.
Quantitative analysis of beta cell size was performed
using a computer-assisted image analysis procedure based
on an Olympus BX 40 microscope (Olympus-France,
France) connected via video camera to a personal computer
and using Visiolab 1000 software (Biocom, France). Beta
cell size was measured by a stereological morphometric
method which calculates on insulin-stained sections the
mean cross-sectional area of individual beta-cells. Beta cell
nuclei were counted on a random section, and the beta
cell area in that section was measured by planimetry. Beta
cell area was divided by the number of nuclei to calculate
the area of individual beta cells.
Analytical methods
Plasma concentration of glucose was determined using
commercial diagnostic kits on a Cobas Mira Plus automatic
analyser (ABX, Shefford, UK) and plasma corticosterone
was determined with a rat corticosterone EIA kit (DSL,
Webster, Tx). Plasma growth hormone level was measured
with a Mouse/Rat GH ELISA kit (DSL, Webster, Tx).
Plasma prolactin concentration was determined with a rat
prolactin ELISA kit (MD Biosciences Inc, MN). Concen-
trations of total and free insulin-like growth factor-I were
determined by immunoenzymometric assay using a Rat/
Mouse IGF-1 IEMA kit (GroPep-IDS, Fountain Hills,
USA). Bound IGF-I, free/total IGF-I and bound/total IGF-I
were calculated from the total and free measured values.
Immunoreactive insulin (IRI) was measured with an
ELISA kit (Mercodia, Uppsala, Sweden). All assays were
performed according to the manufacturer’s instructions.
Genetic markers and genotype determination
Genomic DNA of the F2 rats was prepared from spleens as
previously described (Gauguier et al. 1996). Rat micro-
satellite markers were selected in our linkage maps con-
structed in a GKxBN cross (Wilder et al. 2004) in order to
provide a genome coverage of 10-15 cM between adjacent
loci on average in the new GKxBN F2 cross. Marker
information is available at http://www.well.ox.ac.uk/
rat_mapping_resources. Genotypes of the F2 rats were
determined using a PCR protocol previously described
(Bihoreau et al. 1997). PCR products were separated by
electrophoresis on 4% agarose gels and visualized by
ethidium bromide gel staining for genotype determination.
Oligonucleotides were synthesized by Sigma-Genosys
(Pampisford, UK).
Construction of the genetic maps
Genetic maps were constructed using the JoinMap version
2.0 suite of programs (Stam 1993) as previously described
(Bihoreau et al. 1997). Genotypes were veriﬁed prior to
QTL analysis using JoinMap modules, which calculate for
all loci and for all individuals the probability of obtaining
the present genotype, conditional on both map distances
and genotypes at the two ﬂanking loci.
Statistical methods and QTL analysis
The R (Ihaka and Gentleman 1996) package SMA was
used for testing phenotype correlations. All correlations
between standardised residuals were calculated and plotted
and their signiﬁcance were adjusted for the multiple testing
using the Dunn-S ˇida ´k method (Ury 1976). All phenotypes
were corrected for sex by regression prior to QTL mapping
and the standardized residuals were analyzed for departures
from normality using the Kolmogorov-Smirnov and
Shapiro-Wilk tests (SPSS version 12.0 package, SAS
Institute Inc. Carry, NC). For those variables with signiﬁ-
cant departure from normality, the logarithm-transformed
raw data were regressed by sex, and the standardised
residuals were analysed for departures from normality. All
further linkage analyses were carried out with the stan-
dardized residuals which best ﬁtted the normal distribution.
Linkages between marker genotypes and phenotypes were
initially evaluated using automated ANOVA tests followed
by permutation tests (n = 10,000), which were applied to
calculate the threshold of signiﬁcance for each pair of
genetic-phenotypic marker (Doerge and Churchill 1996).
The genome wide scans were applied using R/qtl (Broman
et al. 2003). Haley-Knott regression (Haley and Knott
1992) was used for each of the standardized variables.
Subsequently, genome scans were generated for the two
sexes to test the existence gender effects in QTL detection.
Finally, we used a two-sample t-test to test whether there
were signiﬁcant differences in standardised phenotypes
between the two cross directions. Correlations between
marker genotypes and phenotypes were calculated using
the SPSS version 16.0 package (SAS Institute Inc. Carry,
NC).
Results
Phenotype investigations in GK and BN strains
To investigate islet architecture in young adult rats of the
strains used to derive the GKxBN F2 cohort, pancreas
histology was carried out in 2 month-old GK and BN rats.
Typical morphological features of GK pancreas include
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123reduction in insulin-positive cell area (IPCA) (Table 1,
Fig. 1a, b) and fragmented appearance and compromised
architecture of islets (Fig. 1c, d), when compared to BN.
Reduction in IPCA in GK was signiﬁcant in both duodenal
and splenic pancreatic segments in males and in the splenic
region in females (Table 1). Accordingly, beta cell mass
(BCM) in both duodenal and splenic segments was sig-
niﬁcantly reduced in both male and female GK rats when
compared to sex-matched BN rats. Body weight was sig-
niﬁcantly lower in BN rats than in sex matched GK.
To document possible causes and/or effects of altered
islet morphology, the concentration of glucose, insulin and
hormones known to play a role in or to be inﬂuenced by
pancreas function were measured in plasma of 2 month-old
GK and BN rats (Table 1). Male and female GK rats
showed signiﬁcant basal hyperglycemia and hyperinsuli-
nemia when compared to BN. Reduced concentration of
plasma prolactin and increased concentration of plasma
corticosterone were observed in male GK when compared
to sex matched BN.
Islet morphological and plasma hormone variables
in F2 (GK 9 BN) hybrids
To evaluate the inheritance of these phenotypic features in
hybrids of a cross between GK and BN rats, we initially
analysed their distribution in F2 hybrids. Pancreata of F2
animals generally displayed levels of IPCA and BCM that
spanned the interval between and extended beyond the
parental strain means but with means intermediate between
the parental strains (Table 1, Supplementary Fig. S1), with
the exception of female duodenal IPCA and BCM, which
were lower on average than the GK mean. Female F2 rats
had signiﬁcantly reduced mean IPCA and BCM when
compared to male F2 rats in both duodenal and splenic
segments of the pancreas (Table 1).
Mean glucose, insulin and corticosterone concentra-
tions in F2 males and females were generally intermediate
between parental means (Table 1). There was a decrease
in the mean of GH and an increase in the means of IGF-1
and prolactin in F2 rats when compared to parental strains
(Table 1, Supplementary Fig. S2). Female F2 rats showed
signiﬁcantly lower insulin and IGF-1 than males. As
expected they also showed higher prolactin than F2
males.
Correlations between phenotypes quantiﬁed
in F2 (GK 9 BN) hybrids
IGF-1, corticosterone, prolactin and glycemia showed no
signiﬁcant correlation with any of the other phenotypes in
the study suggesting independent genetic control (Fig. 2).
Growth hormone concentration was signiﬁcantly positively
associated with IPCA and BCM in the duodenal pancreas
and accordingly with the total IPCA and BCM but the
effect was not signiﬁcant in the splenic pancreas. Con-
versely insulin has a trend towards a positive correlation
with splenic pancreas phenotypes, signiﬁcantly increasing
the total BCM. Body weight was signiﬁcantly correlated
with both duodenal and splenic pancreas weights and
BCM, after adjusting for multiple testing. It was also sig-
niﬁcantly correlated with insulin concentration.
Table 1 Islet histopathological phenotypes, body weight and plasma concentrations of glucose, insulin, growth hormone (GH), insulin growth
factor 1 (IGF-1), corticosterone and prolactin quantiﬁed in BN, GK and (GKxBN) F2 male and female rats
BN GK (GKxBN) F2
Males (6) Females (6) Males (6) Females (6) Males (84) Females (86)
IPCA (duodenal) (%) 0.67 ± 0.07 0.56 ± 0.12 0.34 ± 0.06* 0.39 ± 0.06 0.45 ± 0.02 0.35 ± 0.01
IPCA (splenic) (%) 0.75 ± 0.13 0.80 ± 0.10 0.34 ± 0.05* 0.34 ± 0.04** 0.57 ± 0.02 0.51 ± 0.02
BCM (duodenal) (mg) 1.70 ± 0.12 1.38 ± 0.10 0.87 ± 0.20* 0.95 ± 0.08* 1.10 ± 0.05 0.74 ± 0.03
BCM (splenic) (mg) 3.75 ± 0.28 3.59 ± 0.21 1.08 ± 0.17*** 1.22 ± 0.26*** 2.53 ± 0.11 1.91 ± 0.08
BCM (total) (mg) 5.39 ± 0.30 4.90 ± 0.19 2.00 ± 0.40*** 2.18 ± 0.33*** 3.63 ± 0.13 2.65 ± 0.09
Body weight (g) 191 ± 4 155 ± 6 224 ± 7*** 176 ± 5* 216 ± 3 147 ± 2
Plasma glucose (mM) 7.10 ± 0.17 7.22 ± 0.22 14.37 ± 1.44*** 14.60 ± 0.89*** 11.54 ± 0.17 11.16 ± 0.22
Insulin (pg/ml) 246 ± 43 233 ± 31 723 ± 92** 350 ± 53* 398 ± 17 300 ± 15
GH (ng/ml) 59 ± 10 101 ± 5 66 ± 36 6 ± 23 24 ± 22 0 ± 2
IGF-1 (ng/ml) 846 ± 288 665 ± 48 1180 ± 162 849 ± 76 1930 ± 59 1750 ± 64
Corticosterone (ng/ml) 283 ± 30 441 ± 67 523 ± 86* 604 ± 65 401 ± 25 380 ± 29
Prolactin (ng/ml) 36 ± 5 113 ± 17 7 ± 2** 133 ± 33 62 ± 8 144 ± 10
Beta cell mass (BCM) and insulin-positive cell area (IPCA) were quantiﬁed in the duodenal and splenic regions of the pancreas. Values are
means ± SE. Number of rats is in parentheses. * P\0.05, ** P\0.01, *** P\0.001 signiﬁcantly different between GK and sex matched BN
rats.  P\0.05;  P\0.01;  P\0.001 signiﬁcant sex differences within groups
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123Correlation between splenic and duodenal BCM was
marginally signiﬁcant (Fig. 2). Interestingly, duodenal
IPCA was highly positively correlated with duodenal
BCM, and similarly in the splenic segment, but IPCA was
poorly correlated when comparing between segments,
suggesting independent genetic control of duodenal and
splenic phenotypes in accordance with distinct organo-
genesis of these pancreatic regions.
Genetic map
A genetic map was constructed using genotype data gen-
erated from the 150 markers typed in GKxBN F2 hybrids.
The markers spanned a total distance of 1620 cM
(Kosambi), which is consistent with our previously pub-
lished linkage maps constructed in a similar F2 cross
(Wilder et al. 2004). As expected the average distance
between adjacent loci was 10.8 cM and marker order was
conserved with our previously published maps (Argoud
et al. 2006; Wilder et al. 2004).
Quantitative trait locus mapping
To identify genetic loci controlling islet histopathological
phenotypes and plasma hormones, genotype data from the
genome wide scan carried out in the cross were used to test
for linkage to quantitative phenotypes. Strongest evidence
of linkage to BCM and IPCA in the splenic pancreatic
region was detected with a locus in chromosome 10
(maximum LOD 3.2 at marker locus D10Got156) (Fig. 3a
and Fig. 3b). This locus was denoted Bcm1. Interestingly,
this locus does not show signiﬁcant linkage to IPCA and
BCM in the duodenal region (Fig. 3c and d), thus con-
ﬁrming the independent genetic control of splenic and
duodenal pancreatic phenotypes suggested by the analysis
of correlations. In the cross, GK genotypes at marker locus
D10Got156 are associated with a signiﬁcant reduction in
IPCA (Fig. 3e) and BCM (Fig. 3f) in the splenic pancreas,
but no signiﬁcant differences in either measure in the
Fig. 1 Pancreas histology in
rats of the inbred BN (a, c) and
GK (b, d) strains. Pancreas
sections (7 lm) stained for
insulin show the overall
reduction in insulin-positive cell
area in GK (b) rats compared to
BN (a). Further magniﬁcation
shows fragmented appearance
and compromised architecture
of the GK islets (d) when
compared to BN (c)
Fig. 2 Pearson correlations between phenotypes quantiﬁed in the
GK 9 BN F2 cross (see Table 1). Each comparison is based on
phenotypes regressed for sex effects acquired in over 143 F2 hybrids.
Statistically signiﬁcant (2-tailed) correlations are shown on yellow
(P\0.05) or red (P\0.001) backgrounds. Duo duodenal segment,
spl splenic segment, BCM Beta cell mass, IPC insulin-positive cells
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123duodenal pancreas (data not shown). The effect in males
alone was largely responsible for generating this QTL
(Fig. 3e and f). Consistent linkages to IPCA and BCM in
the duodenal pancreas were found in a region of chromo-
some 7 signiﬁcantly linked to body weight in the cross (data
not shown) and in a previous GKxBN F2 cross (Gauguier
et al. 1996), but these effects were not statistically signiﬁ-
cant (maximum LOD 2.10 for IPCA) (Fig. 3c and d).
A highly signiﬁcant QTL for plasma corticosterone
concentration was detected on rat chromosome 1 (maxi-
mum LOD 4.2 at marker D1Got308) (Fig. 4a and Fig. 4b).
This locus was denoted Pcort1. F2 animals that were
homozygous for the GK allele or heterozygous at marker
locus D1Got308 showed signiﬁcantly reduced plasma
corticosterone when compared to BN homozygous F2 rats
at the same locus (Fig. 4c). This dominant effect of GK
alleles at the locus on corticosterone levels was signiﬁcant
in both males and females.
No signiﬁcant linkages to plasma GH, prolactin or IGF-
1 were found when data from the full cohort were analysed
(Supplementary Fig. S3). However, the single-sex genome
scans indicated the existence of male-speciﬁc QTLs in the
cross. The most marked differences were found for plasma
GH and prolactin, which showed evidence of linkages
(LOD[4) in male rats to loci D6Got166 on chromosome
6 (GH) and D17Rat34 on chromosome 17 (prolactin),
whereas signiﬁcance all but disappeared when considering
females (data not shown). At both loci GK alleles were
associated with increased concentrations of plasma GH and
prolactin (Fig. S3e and Fig. S3f, Supplementary material)
and showed a recessive effect on these variables.
Discussion
We have mapped genetic determinants of intrinsic islet
phenotypes and circulating factors in the GK rat model of
type 2 diabetes. The description of new QTLs linked to
these variables provides new insights into the etiology of
diabetes related phenotypes in this strain and underlines the
Fig. 3 Genome-wide genetic linkage analysis for beta cell mass
(BCM) (a, c) and insulin-positive cell area (IPCA) (b, d) in the
splenic (a, b) and duodenal (c, d) regions of the pancreas in the
GK 9 BN F2 cross. LOD scores are plotted against map distance
calculated in the cross in centimorgans (cM). Dotted lines indicate
statistically signiﬁcant threshold of linkages (P = 0.001) to pheno-
types determined by permutation tests (n = 10,000). Bar graphs (e–
h) show the phenotypic effects of GK and BN alleles at the
chromosome 10 marker D10Got156, which was signiﬁcantly
associated with BCM and IPCA in the splenic pancreatic region
(spl) (e, f), and at the chromosome 7 marker D7Got88, which showed
the strongest effects on BCM and IPCA in the duodenal pancreatic
region (duo) (g, h). Phenotype means were calculated in males and
females according to the genotype homozygous for the BN allele
(black bar), heterozygous (hatched bar) or homozygous for the GK
allele (white bar) at the loci. Number of rats carrying each genotype is
shown in the bar chart. Results from the F-test and P-values are
reported
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123multiple and complex molecular mechanisms that collec-
tively regulate islet function and have to be considered in
diabetes genetic studies. These results complement previ-
ous studies that demonstrated anomalies in the genetic
control of insulin secretion in this strain (Collins et al.
2006; Gauguier et al. 1996; Wallace et al. 2004; Wallis
et al. 2004, 2008).
Genetic investigations into the causes of reduced beta
cell mass are central to our understanding of molecular
mechanisms which, in combination with insulin resistance,
are involved in the onset and progression of type 2 diabetes
(Kahn et al. 2009). However, screening phenotypes rele-
vant to these clinical features represents a major challenge
in human genetics. The GK strain, which exhibits both
insulin resistance and structural and functional anomalies
of the endocrine pancreas (Portha 2005), provides a pow-
erful experimental system to establish an etiological basis
for these phenotypes. Genetic studies in this strain have
primarily focused on metabolic phenotypes (Dumas et al.
2007) and biological variables related to glucose regula-
tion, lipid homeostasis (Argoud et al. 2006; Gauguier et al.
1996) and insulin secretion (Gauguier et al. 1996) in the
same GK-BN strain combination. The QTL Bcm1 relevant
to pancreas histology does not coincide with previously
detected QTLs in the GK rat. Positional and functional
candidate genes for Bcm1 include genes encoding GH,
signal transducers and activators of transcription (Stat3,
Stat5), which play central roles in mediating the biological
effects of prolactin and GH in beta cells (Brelje et al. 2004;
Mziaut et al. 2008), and the suppressor of cytokine
signaling Socs-3, which inhibits GH-promoted beta-cell
proliferation (Lindberg et al. 2005). In addition, micro-
array-based gene transcription proﬁling data showed that
Stat3 is signiﬁcantly overexpressed in GK (Hu et al. 2009).
Results from our genetic study showed a lack of corre-
lation between islet morphological traits derived from
distinct regions of the pancreas suggesting an apparent
distinct genetic control of these phenotypes in the cross.
The identiﬁcation of genetic loci linked to histopatholo-
gical phenotypes in duodenal and splenic regions, which
largely correspond to pancreatic head and tail, respectively
and have distinct embryological origins (Gittes 2009;
Habener et al. 2005), may underlie mechanisms involved in
the complex organogenesis of the endocrine pancreas.
Even though beta cell mass is reduced in both pancreatic
regions in type 2 diabetes (Rahier et al. 2008), density of
islets and beta cells is very different in rodents, the tail of
the pancreas containing higher number of islets and beta
cells than the head (Rahier et al. 1983). The proportion of
alpha-, delta- and PP-cells also differs in these regions. The
QTL Bcm1 linked to beta cell mass in the splenic pancreas
region may shed light on genes that cause an imbalance
between apoptosis and replication/neogenesis in this islet
rich region of the pancreas. Strongest linkage to islet
Fig. 4 Genetic control of plasma corticosterone concentration by the
locus Pcort1 in the GKxBN F2 cross. LOD scores are plotted against
markers mapped across the genome (a). Map distances calculated in
the cross are reported in centimorgans (cM). Mapping details of the
most signiﬁcant QTL (LOD 4.2) in chromosome 1 are shown (b).
Allelic effects on plasma corticosterone levels were calculated in
males and females according to the genotypes homozygous for the
BN allele (black bar), heterozygous (hatched bar) or homozygous for
the GK allele (white bar) at marker locus D1Got308 (c). Number of
rats carrying each genotype is shown in the bar chart. Results from the
F-test and P-values are reported
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123phenotypes in the duodenal region of the pancreas was
found at a locus of chromosome 7 signiﬁcantly linked to
body weight in this cross (LOD[7, data not shown) and
in a previous GKxBN cross (Gauguier et al. 1996), sug-
gesting a role of the underlying gene on islet growth. The
identiﬁcation of genes accounting for these islet histopa-
thology phenotypes may provide new insights into
molecular mechanisms that contribute to the maintenance
of endocrine pancreas integrity.
To complement the genetic mapping of endocrine pan-
creas structural phenotypes, we investigated in the cross the
genetic basis of the control of circulating factors known to
have broad regulatory roles in islet function, development
and survival, including IGF-1, prolactin, GH and cortico-
sterone. Prolactin and GH are potent growth factors which
up-regulate pancreatic beta-cell function and mass (Ben-
Jonathan et al. 2006; Zhang et al. 2009). They stimulate
insulin gene transcription and secretion, increase beta-cell
proliferation and inhibit beta-cell apoptosis (Ben-Jonathan
et al. 2006; Brelje et al. 1993; Zhang et al. 2009). In
contrast, glucocorticoids have opposing biological effects
(Weinhaus et al. 2000). They inhibit beta-cell proliferation,
reduce beta-cell viability, down regulate insulin production
and secretion in vivo and in vitro (Lambillotte et al. 1997;
Ranta et al. 2006) and contribute to insulin resistance
(Andrews and Walker 1999). No signiﬁcant linkage to
plasma IGF-1 was found, and male-speciﬁc genetic effects
on the control of plasma GH and prolactin concentrations
were detected in chromosomes 6 and 17, respectively. The
highly signiﬁcant QTL Pcort1 linked to plasma cortico-
sterone was detected in a region of rat chromosome 1
which maps[30 cM away from QTLs linked to glucose
tolerance, adiposity, insulin secretion (Gauguier et al.
1996) and cholesterol metabolism (Argoud et al. 2006)i n
GKxBN F2 crosses. This QTL is distinct to the locus
Scort1 for serum corticosterone identiﬁed in an hyperten-
sive rat strain, which maps to the telomeric end of chro-
mosome 1 (Bilusic et al. 2004).
GK alleles are associated with increased concentrations
of plasma GH and prolactin at both QTLs mapped to
chromosomes 6 and 17, and reduced concentration of
corticosterone at the QTL Pcort1. The effects of GK alleles
would synergistically result in enhanced islet cell function
and insulin secretion, and may compensate for the pheno-
typic consequences of GK alleles at other loci, including
Bcm1 and QTLs linked to impaired glucose homeostasis.
They are consistent with the role of GK alleles at previ-
ously described QTLs in GKxBN crosses which are asso-
ciated with enhanced insulin secretion in vivo in response
to arginine and glucose (Gauguier et al. 1996). The bio-
logical effects of GK alleles on increased beta cell mass
and enhanced insulin secretion in vivo and in vitro have
been demonstrated in a GK.BN congenic strain containing
GK haplotypes in a large region of chromosome 1 covering
Pcort1 and QTLs associated with insulin secretion, glucose
tolerance, adiposity and plasma cholesterol (Wallis et al.
2008).
Genetic analysis of phenotypes measured in an F2
cohort combining female and male hybrids provided us
with an opportunity to address sex-speciﬁc genetic control
of islet morphological and hormonal phenotypes. As pre-
viously reported for the genetic control of glucose toler-
ance (Gauguier et al. 1996) and cholesterol metabolism
(Argoud et al. 2006) in other GK 9 BN F2 cohorts, we
identiﬁed signiﬁcant or suggestive sex-speciﬁc loci linked
to islet structural features and plasma hormones (BCM,
IPCA, GH, prolactin) that are mostly due to an effect in
males. We also noted female speciﬁc dominant effects of
GK alleles on islet structural phenotypes in the duodenal
pancreatic region. Sexual dimorphism is a hallmark of
genetic studies of complex traits (Weiss et al. 2006). It may
implicate sex-speciﬁc responsiveness to environmental
factors and interactions between autosomal QTLs and
chromosome X loci that congenic strains, where alleles in
this chromosome do no segregate (Collins et al. 2006), can
help investigate.
Collectively, results from our genetic studies suggest an
involvement of genes causing islet structural and functional
changes in the etiology of diabetes in the GK rat. Even
though the GK strain was produced through repeated
breeding of rats selected on the sole criterion of glucose
intolerance (Goto et al. 1988), suggesting the eventual
isolation of natural variants that predominantly contribute
to impaired glucose homeostasis, we have been able to
identify gene loci involved in islet structure and function.
These gene variants may have randomly aggregated in the
GK during the process of selective breeding or may have
been isolated to either compensate or further deteriorate
insulin resistance. The intricate roles of insulin resistance
and beta cell dysfunction in diabetes pathogenesis is
illustrated by the observation that partial pancreatectomy
has little impact on glucose homeostasis unless glucose
intolerance or preexisting beta cell dysfunction are present
(Menge et al. 2009; Slezak and Andersen 2001).
Results from this study provide novel insights into eti-
ological factors that contribute to diabetes in the GK and
complement previous genetic studies in this strain which
primarily focused on glucose tolerance, insulin secretion
and metabolic phenotypes. Genetic investigations in the
GK suggest a predominant role of insulin resistance in the
etiology of diabetes in this strain that can be further
investigated in combination with islet morphological phe-
notypes in congenic strains to ﬁne map the underlying
genes and characterise their function (Collins et al. 2006;
Wallis et al. 2008). There are important differences in islet
architecture and cellular composition between humans and
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123rodents (Steiner et al. 2010) that may hamper translational
studies of rodent genetic and physiological data in humans.
Genetic studies dissecting diabetes related variables in a
rodent model of spontaneous type 2 diabetes demonstrate
the complex phenotypic consequences of naturally occur-
ring variants which collectively contribute to the diabetic
phenotype.
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